Department of Pharmaceutical Technology


    email: bmilan@ump.edu.pl
    phone: 61 854 66 59


    Bartłomiej Milanowski graduated with M.Sc. in pharmacy (2003) and Ph.D. in pharmaceutical sciences (2012, doctoral dissertation title: “An evaluation of the impact of P-glycoprotein on the disposition of selected chiral polychlorinated biphenyl congeners in mice”, advisor: Prof. Janina Lulek, Ph.D.) from the Poznan University of Medical Sciences (PUMS). He has obtained international research experience as research assistant in Dr. Lehmler’s lab at Department of Occupational and Environmental Health, College of Public Health, University of Iowa, IA, US (2007-2008) and as a scientist in R&D department of GlaxoSmithKline (2010). Currently, he is an Assistant Professor at the Department of Pharmaceutical Technology at the PUMS and a board member of University Centre for Medical Technology Transfer in Poznan, Poland.  He is also scientific consultant for several pharmaceutical companies. Since 2009, he has been a member of Polish Pharmaceutical Society (PTFarm), American Association of Pharmaceutical Sciences (AAPS), Controlled Release Society (CRS) and International Society of Pharmaceutical Engineering (SIPE). Dr Milanowski’s main scientific interests are focused on predictive drug release and dissolution testing, in vitro-in vivo correlation (IVIVC) and in silico modelling tools to support biopharmaceutical evaluation of oral and dermal formulations, preformulation, formulation computer aided design and new process technologies. He has supervised numerous M.Sc. students and is co-supervisor of one Ph.D. student. He is the author and co-author of several peer-reviewed scientific papers and multiple conference abstracts in the area of pharmaceutical technology.

    Recent publications:

    1. Voelkel A., Milczewska K., Teżyk M., Milanowski B., Lulek J. Evaluation of drug-carrier interactions in quaternary powder mixtures containing perindopril tert-butylamine and indapamide. Int J Pharm. 2016 Feb 25 pii: S0378-5173(16)30145-4. [Epub ahead of print] DOI: 10.1016/ j.ijpharm.2016.02.040

    2. Osmałek T., Milanowski B., Froelich A., Górska S., Białas W., Szybowicz M., Kapela M. Novel organogels for topical delivery of Naproxen: physicochemical Characteristics and in vitro drug permeation. Pharm Dev Technol. 2016 Jan 20:1-16 [Epub ahead of print] DOI: 10.3109/10837450.2015.1135342

    3. Teżyk M., Milanowski B., Ernst A., Lulek J. Recent progress in continuous and semi-continuous processing of solid oral dosage forms: a review. Drug Dev Ind Pharm. 2015 Dec 18:1-20 [Epub ahead of print] DOI: 10.3109/03639045. 2015.1122607

    4. Skotnicki M., Apperley D.C., Aguilar J.A., Milanowski B., Pyda M., Hodgkinson P. Characterization of Two Distinct Amorphous Forms of Valsartan by Solid-State NMR. Mol Pharm. 2016 13(1):211-222.

    5. Karaźniewicz-Łada M., Milanowski B., Lulek J., Główka F. Dissolution kinetics studies of clopidogrel from selected multisource coated tablets with application of capillary zone electrophoresis method. Acta Pol Pharm. 2016 73(1):197-207.

    6. Kiwilsza A., Milanowski B., Drużbicki K., Coy L.E., Grzeszkowiak M., Jarek M., Mielcarek J., Lulek J., Pajzderska A., Wąsicki J. Mesoporous drug carrier systems for enhanced delivery rate of poorly water-soluble drug: nimodipine. J. Porous Mat. 2015 22(3):817-829

    7. E. Kaminska, K. Adrjanowicz, D. Zakowiecki, B. Milanowski, M. Tarnacka, L. Hawelek, M. Dulski, J. Pilch, W. Smolka, I. Kaczmarczyk-Sedlak, K. Kaminski: Enhancement of the Physical Stability of Amorphous Indomethacin by Mixing it with Octaacetylmaltose. Inter and Intra Molecular Studies. Pharm. Res. 2014 31(10):2887-2903